Since 1989, NCBiotech has invested in more than 255 North Carolina life sciences companies through our loan and convertible note programs. These investments have led to nearly 50 mergers and acquisitions and IPOs. Companies receiving investment from NCBiotech's loan program have gone on to raise $140 in follow-on funding for each $1 invested by NCBiotech. Read our success stories on the tab below.
Our active investment portfolio includes over 70 companies in therapeutics, medical device, diagnostics, health IT, ag tech, and other areas of the life sciences.